Community participation in AIDS vaccine trials: Empowerment or science?

Social Science and Medicine

Volumn 63, Issue 5, 2006, Pages 1143-1146

  Swartz, Leslie ^a   Kagee, Ashraf ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Aids vaccines; Clinical trials; Empowerment; Participation; Public understanding of science

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EMPOWERMENT; LOCAL PARTICIPATION; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COMMUNITY; EMPOWERMENT; ETHICS; HUMAN; INFECTION RISK;

AIDS VACCINES; CLINICAL TRIALS, PHASE III; CLINICAL TRIALS, PHASE III AS TOPIC; CONSUMER PARTICIPATION; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; PATIENT SELECTION;

EID: 33745828102     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2006.03.032     Document Type: Article

References (12)

1. Buchbinder S., Metch B., Holte S.E., Scheer S., Coletti A., and Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial. Journal of Acquired Immune Deficiency Syndrome 36 (2004) 604-615
2. Campbell C. Letting them die: Why HIV AIDS prevention programmes fail (2003), The International African Institute in association with James Currey, Oxford
3. Heyward W.L., Osmanov S., Saba J., Esparz a.J., Belsey E., Stonebumer R., et al. Preparation for phase III HIV vaccine efficacy trials: Methods for the determination of HIV incidence. AIDS 8 (1994) 1285-1291
4. HIV Prevention Trials Network (2005). HPTN community involvement and participation. Downloaded from http://www.hptn.org/community_program.htm, 14 December 2005.
5. Jennings M.K., and Andersen E.A. The importance of social and political context: The case of AIDS activism. Political Behavior 25 (2003) 177-199
6. In: Kahn P. (Ed). AIDS vaccine handbook: Global perspectives (2005), AIDS Vaccine Advocacy Coalition, New York
7. Kiwanuka N., Robb M., Kigozi G., Brix D., Phillips J., and Wabwire-Mangen F. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials. Journal of Acquired Immune Deficiency Syndrome 36 (2004) 721-726
8. Koblin B.A., Holte S., Lenderking B., and Heagerty P. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. Journal of Acquired Immune Deficiency Syndrome 24 (2000) 451-457
9. In: Leach M., Scoones I., and Wynne B. (Eds). Science and citizens : Globalization and the challenge of engagement (2005), Zed Books, London
10. Robins S. 'Long live Zackie. long live': AIDS activism, science and citizenship after apartheid. Journal of Southern African Studies 30 (2004) 651-672
11. Shisana O., Rehle T., Simbayi L.C., Parker W., Zuma K., Bhana A., et al. South African national HIV prevalence, HIV incidence behavioural risks and communication survey 2005 (2005), HSRC Press, Cape Town
12. UNAIDS. AIDS epidemic update (2004), Geneva, Switzerland, UNAIDS/WHO